> top > docs > PMC:3342329 > spans > 21382-23408 > annotations

PMC:3342329 / 21382-23408 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T8960 1958-1962 Protein denotes CCR5
T8959 1888-1894 Protein denotes IL-1Ra
T8958 1803-1807 Protein denotes CCR5
T8957 1770-1778 Positive_regulation denotes elevated
T8956 1744-1750 Protein denotes IL-1Ra
T8955 1656-1666 Gene_expression denotes production
T8954 1642-1646 Protein denotes IL-6
T8953 1633-1641 Negative_regulation denotes inhibits
T8952 1623-1631 Protein denotes icIL-1Ra
T8951 1601-1621 Protein denotes Intracellular IL-1Ra
T8950 1477-1483 Protein denotes IL-1Ra
T8949 1388-1394 Regulation denotes change
T8948 1368-1374 Protein denotes IL-1Ra
T8947 1354-1364 Gene_expression denotes expression
T8946 1345-1353 Positive_regulation denotes elevated
T8945 971-978 Regulation denotes effects
T8944 933-939 Protein denotes IL-1Ra
T8943 628-635 Regulation denotes effects
T8942 599-607 Negative_regulation denotes abrogate
T8941 589-595 Protein denotes IL-1Ra
T8940 405-410 Protein denotes IL-10
T8939 301-309 Negative_regulation denotes inhibits
T8938 295-300 Protein denotes IL-10
T8937 199-204 Protein denotes IL-10
T8936 183-197 Protein denotes interleukin 10
T8935 119-123 Protein denotes IL-6
T8878 1958-1962 Protein denotes CCR5
T8877 1888-1894 Protein denotes IL-1Ra
T8876 1803-1807 Protein denotes CCR5
T8875 1744-1750 Protein denotes IL-1Ra
T8874 1642-1646 Protein denotes IL-6
T8873 1623-1631 Protein denotes icIL-1Ra
T8872 1601-1621 Protein denotes Intracellular IL-1Ra
T8871 1477-1483 Protein denotes IL-1Ra
T8870 1368-1374 Protein denotes IL-1Ra
T8869 933-939 Protein denotes IL-1Ra
T8868 589-595 Protein denotes IL-1Ra
T8867 405-410 Protein denotes IL-10
T8866 295-300 Protein denotes IL-10
T8865 199-204 Protein denotes IL-10
T8864 183-197 Protein denotes interleukin 10
T8863 119-123 Protein denotes IL-6
R5903 T8937 T8936 equivalentTo IL-10,interleukin 10
R5904 T8947 T8946 themeOf expression,elevated
R5905 T8948 T8947 themeOf IL-1Ra,expression
R5906 T8951 T8953 causeOf Intracellular IL-1Ra,inhibits
R5907 T8952 T8951 equivalentTo icIL-1Ra,Intracellular IL-1Ra
R5908 T8954 T8955 themeOf IL-6,production
R5909 T8955 T8953 themeOf production,inhibits

testone

Id Subject Object Predicate Lexical cue
T8835 1770-1778 Positive_regulation denotes elevated
T8834 1656-1666 Gene_expression denotes production
T8833 1633-1641 Negative_regulation denotes inhibits
T8832 1388-1394 Regulation denotes change
T8831 1354-1364 Gene_expression denotes expression
T8830 1345-1353 Positive_regulation denotes elevated
T8829 971-978 Regulation denotes effects
T8828 946-954 Regulation denotes regulate
T8827 599-607 Negative_regulation denotes abrogate
T8776 933-939 Protein denotes IL-1Ra
T8775 589-595 Protein denotes IL-1Ra
T8774 405-410 Protein denotes IL-10
T8773 295-300 Protein denotes IL-10
T8772 199-204 Protein denotes IL-10
T8771 183-197 Protein denotes interleukin 10
T8770 119-123 Protein denotes IL-6
T8785 1958-1962 Protein denotes CCR5
T8784 1888-1894 Protein denotes IL-1Ra
T8783 1803-1807 Protein denotes CCR5
T8782 1744-1750 Protein denotes IL-1Ra
T8781 1642-1646 Protein denotes IL-6
T8780 1623-1631 Protein denotes icIL-1Ra
T8779 1601-1621 Protein denotes Intracellular IL-1Ra
T8778 1477-1483 Protein denotes IL-1Ra
T8777 1368-1374 Protein denotes IL-1Ra
R5876 T8772 T8771 equivalentTo IL-10,interleukin 10
R5877 T8777 T8831 themeOf IL-1Ra,expression
R5878 T8779 T8833 causeOf Intracellular IL-1Ra,inhibits
R5879 T8780 T8779 equivalentTo icIL-1Ra,Intracellular IL-1Ra
R5880 T8781 T8834 themeOf IL-6,production
R5881 T8782 T8835 themeOf IL-1Ra,elevated
R5890 T8829 T8828 themeOf effects,regulate
R5891 T8831 T8830 themeOf expression,elevated
R5892 T8834 T8833 themeOf production,inhibits

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T11140 1958-1962 Protein denotes CCR5
T11139 1888-1894 Protein denotes IL-1Ra
T11138 1803-1807 Protein denotes CCR5
T11137 1744-1750 Protein denotes IL-1Ra
T11136 1642-1646 Protein denotes IL-6
T11135 1623-1631 Protein denotes icIL-1Ra
T11134 1601-1621 Protein denotes Intracellular IL-1Ra
T11133 1477-1483 Protein denotes IL-1Ra
T11132 1368-1374 Protein denotes IL-1Ra
T11131 933-939 Protein denotes IL-1Ra
T11130 589-595 Protein denotes IL-1Ra
T11129 405-410 Protein denotes IL-10
T11128 295-300 Protein denotes IL-10
T11127 199-204 Protein denotes IL-10
T11126 183-197 Protein denotes interleukin 10
T11125 119-123 Protein denotes IL-6
T11182 1770-1778 Positive_regulation denotes elevated
T11181 1656-1666 Gene_expression denotes production
T11180 1633-1641 Negative_regulation denotes inhibits
T11179 1354-1364 Gene_expression denotes expression
T11178 1345-1353 Positive_regulation denotes elevated
R7394 T11132 T11179 themeOf IL-1Ra,expression
R7396 T11134 T11180 causeOf Intracellular IL-1Ra,inhibits
R7398 T11136 T11181 themeOf IL-6,production
R7400 T11137 T11182 themeOf IL-1Ra,elevated
R7421 T11179 T11178 themeOf expression,elevated
R7423 T11181 T11180 themeOf production,inhibits

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T10798 183-197 Protein denotes interleukin 10
T10797 119-123 Protein denotes IL-6
T10812 1958-1962 Protein denotes CCR5
T10811 1888-1894 Protein denotes IL-1Ra
T10810 1803-1807 Protein denotes CCR5
T10809 1744-1750 Protein denotes IL-1Ra
T10808 1642-1646 Protein denotes IL-6
T10807 1623-1631 Protein denotes icIL-1Ra
T10806 1601-1621 Protein denotes Intracellular IL-1Ra
T10805 1477-1483 Protein denotes IL-1Ra
T10804 1368-1374 Protein denotes IL-1Ra
T10803 933-939 Protein denotes IL-1Ra
T10802 589-595 Protein denotes IL-1Ra
T10801 405-410 Protein denotes IL-10
T10800 295-300 Protein denotes IL-10
T10799 199-204 Protein denotes IL-10
T10858 1770-1778 Positive_regulation denotes elevated
T10857 1656-1666 Gene_expression denotes production
T10856 1633-1641 Negative_regulation denotes inhibits
T10855 1354-1364 Gene_expression denotes expression
T10854 1345-1353 Positive_regulation denotes elevated
R7314 T10804 T10855 themeOf IL-1Ra,expression
R7330 T10855 T10854 themeOf expression,elevated
R7331 T10857 T10856 themeOf production,inhibits
R7315 T10808 T10857 themeOf IL-6,production
R7316 T10809 T10858 themeOf IL-1Ra,elevated

bionlp-st-ge-2016-coref

Id Subject Object Predicate Lexical cue
T9156 1213-1236 Anaphor denotes the receptor antagonist
T9155 933-939 Antecedent denotes IL-1Ra
T9154 1063-1081 Anaphor denotes its own antagonist
R5955 T9154 T9155 boundBy its own antagonist,IL-1Ra
R5956 T9156 T9155 boundBy the receptor antagonist,IL-1Ra

2_test

Id Subject Object Predicate Lexical cue
22567084-21685479-91707039 174-176 21685479 denotes 41
22567084-11244051-91707040 284-286 11244051 denotes 42
22567084-15670894-91707041 290-292 15670894 denotes 43
22567084-10542212-91707042 356-358 10542212 denotes 44
22567084-9366558-91707043 373-375 9366558 denotes 45
22567084-15670894-91707044 524-526 15670894 denotes 43
22567084-1838480-91707045 645-647 1838480 denotes 46
22567084-11053091-91707046 1028-1030 11053091 denotes 47
22567084-15042672-91707047 1584-1586 15042672 denotes 14
22567084-12851675-91707048 1590-1592 12851675 denotes 15
22567084-10326864-91707049 1596-1598 10326864 denotes 16
22567084-12901852-91707050 1711-1713 12901852 denotes 37

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T10089 1596-1598 CD denotes 16
T10088 1595-1596 -LRB- denotes [
T10087 1593-1594 -COMMA- denotes ,
T10086 1592-1593 -RRB- denotes ]
T10085 1590-1592 CD denotes 15
T10084 1589-1590 -LRB- denotes [
T10083 1587-1588 -COMMA- denotes ,
T10082 1586-1587 -RRB- denotes ]
T10081 1584-1586 CD denotes 14
T10080 1583-1584 -LRB- denotes [
T10079 1576-1582 NN denotes cancer
T10078 1571-1575 NN denotes skin
T10077 1567-1570 CC denotes and
T10076 1565-1566 -COMMA- denotes ,
T10075 1559-1565 NN denotes breast
T10074 1557-1558 -COMMA- denotes ,
T10073 1549-1557 NN denotes prostate
T10072 1546-1548 IN denotes in
T10071 1534-1545 NN denotes progression
T10070 1528-1533 NN denotes tumor
T10069 1520-1527 VB denotes inhibit
T10068 1517-1519 TO denotes to
T10067 1511-1516 VB denotes shown
T10066 1506-1510 VB denotes been
T10065 1502-1505 VB denotes has
T10064 1495-1501 NN denotes IL-1Ra
T10063 1487-1493 NN denotes tumors
T10062 1484-1486 IN denotes in
T10061 1477-1483 NN denotes IL-1Ra
T10060 1474-1476 IN denotes by
T10059 1461-1473 VB denotes dysregulated
T10058 1458-1460 VB denotes be
T10057 1454-1457 MD denotes may
T10056 1447-1453 NN denotes system
T10055 1432-1446 JJ denotes IL-1-signaling
T10054 1428-1431 DT denotes the
T10053 1423-1427 IN denotes that
T10052 1414-1422 VB denotes suggests
T10051 1412-1413 -COMMA- denotes ,
T10050 1406-1412 NN denotes tumors
T10049 1403-1405 IN denotes in
T10048 1398-1402 NN denotes IL-1
T10047 1395-1397 IN denotes of
T10046 1388-1394 NN denotes change
T10045 1384-1387 DT denotes any
T10044 1376-1383 IN denotes without
T10043 1374-1375 -COMMA- denotes ,
T10042 1368-1374 NN denotes IL-1Ra
T10041 1365-1367 IN denotes of
T10040 1354-1364 NN denotes expression
T10039 1345-1353 VB denotes elevated
T10038 1341-1344 DT denotes The
T10037 1325-1339 NN denotes refractoriness
T10036 1322-1324 IN denotes of
T10035 1316-1321 NN denotes state
T10034 1306-1315 JJ denotes temporary
T10033 1304-1305 DT denotes a
T10032 1295-1303 VB denotes creating
T10031 1291-1294 CC denotes and
T10030 1281-1290 NN denotes signaling
T10029 1276-1280 NN denotes IL-1
T10028 1272-1275 RP denotes off
T10027 1264-1271 VB denotes turning
T10026 1260-1263 IN denotes for
T10025 1250-1259 NN denotes mechanism
T10024 1248-1249 DT denotes a
T10023 1237-1247 VB denotes represents
T10022 1226-1236 NN denotes antagonist
T10021 1217-1225 NN denotes receptor
T10020 1213-1216 DT denotes the
T10019 1210-1212 IN denotes of
T10018 1196-1209 NN denotes Up-regulation
T10017 1188-1194 NN denotes tissue
T10016 1179-1187 JJ denotes diseased
T10015 1175-1178 CC denotes and
T10014 1168-1174 JJ denotes normal
T10013 1165-1167 IN denotes in
T10012 1155-1164 NN denotes signaling
T10011 1150-1154 NN denotes IL-1
T10010 1147-1149 IN denotes of
T10009 1133-1146 NN denotes dysregulation
T10008 1129-1132 CC denotes and
T10007 1118-1128 NN denotes regulation
T10006 1114-1117 DT denotes the
T10005 1100-1113 VB denotes understanding
T10004 1097-1099 IN denotes in
T10003 1088-1096 NN denotes interest
T10002 1085-1087 IN denotes of
T10001 1082-1084 VB denotes is
T10000 1071-1081 NN denotes antagonist
T9999 1067-1070 JJ denotes own
T9998 1063-1066 PRP-DOLLAR- denotes its
T9997 1056-1062 VB denotes induce
T9996 1053-1055 TO denotes to
T9995 1048-1052 NN denotes IL-1
T9994 1045-1047 IN denotes of
T9993 1037-1044 NN denotes ability
T9992 1033-1036 DT denotes The
T9991 1030-1031 -RRB- denotes ]
T9990 1028-1030 CD denotes 47
T9989 1027-1028 -LRB- denotes [
T9988 1017-1026 NN denotes functions
T9987 1013-1016 PRP-DOLLAR- denotes its
T9986 1004-1012 VB denotes blocking
T9985 990-1003 RB denotes competitively
T9984 987-989 IN denotes by
T9983 982-986 NN denotes IL-1
T9982 979-981 IN denotes of
T9981 971-978 NN denotes effects
T9980 959-970 JJ denotes pleiotropic
T9979 955-958 DT denotes the
T9978 946-954 VB denotes regulate
T9977 943-945 TO denotes to
T9976 940-942 VB denotes is
T9975 933-939 NN denotes IL-1Ra
T9974 930-932 IN denotes of
T9973 921-929 NN denotes function
T9972 915-920 JJ denotes major
T9971 911-914 DT denotes the
T9970 906-910 IN denotes that
T9969 897-905 VB denotes indicate
T9968 891-896 NN denotes years
T9967 888-890 CD denotes 10
T9966 883-887 JJ denotes past
T9965 879-882 DT denotes the
T9964 874-878 IN denotes over
T9963 866-873 NN denotes studies
T9962 858-865 JJ denotes various
T9961 855-857 IN denotes of
T9960 847-854 NN denotes results
T9959 843-846 DT denotes The
T9958 832-841 NN denotes promotion
T9957 826-831 NN denotes tumor
T9956 823-825 TO denotes to
T9955 815-822 VB denotes leading
T9954 809-814 NN denotes death
T9953 804-808 NN denotes cell
T9952 794-803 JJ denotes apoptotic
T9951 791-793 IN denotes of
T9950 779-790 NN denotes suppression
T9949 775-778 DT denotes the
T9948 771-774 CC denotes and
T9947 769-770 -COMMA- denotes ,
T9946 758-769 NN denotes progression
T9945 752-757 NN denotes cycle
T9944 747-751 NN denotes cell
T9943 737-746 VB denotes increases
T9942 733-736 CC denotes and
T9941 731-732 -COMMA- denotes ,
T9940 724-731 NN denotes cancers
T9939 716-723 JJ denotes several
T9938 713-715 IN denotes in
T9937 707-712 NN denotes NF-κB
T9936 704-706 IN denotes of
T9935 693-703 NN denotes activation
T9934 689-692 DT denotes the
T9933 681-688 VB denotes induces
T9932 676-680 NN denotes IL-1
T9931 671-675 IN denotes that
T9930 662-670 VB denotes reported
T9929 657-661 VB denotes been
T9928 653-656 VB denotes has
T9927 650-652 PRP denotes It
T9926 647-648 -RRB- denotes ]
T9925 645-647 CD denotes 46
T9924 644-645 -LRB- denotes [
T9923 639-643 NN denotes IL-1
T9922 636-638 IN denotes of
T9921 628-635 NN denotes effects
T9920 612-627 JJ denotes proinflammatory
T9919 608-611 DT denotes the
T9918 599-607 VB denotes abrogate
T9917 596-598 TO denotes to
T9916 589-595 NN denotes IL-1Ra
T9915 586-588 IN denotes of
T9914 578-585 NN denotes ability
T9913 574-577 DT denotes the
T9912 561-573 VB denotes demonstrated
T9911 556-560 VB denotes have
T9910 548-555 NN denotes studies
T9909 540-547 JJ denotes several
T9908 538-539 -COMMA- denotes ,
T9907 529-538 RB denotes Similarly
T9906 526-527 -RRB- denotes ]
T9905 524-526 CD denotes 43
T9904 523-524 -LRB- denotes [
T9903 518-522 NN denotes mice
T9902 502-517 JJ denotes Colon26-bearing
T9901 499-501 IN denotes in
T9900 489-498 NN denotes apoptosis
T9899 485-488 CC denotes and
T9898 475-484 NN denotes caspase-3
T9897 472-474 IN denotes of
T9896 461-471 NN denotes activation
T9895 457-460 DT denotes the
T9894 449-456 IN denotes through
T9893 441-448 NN denotes effects
T9892 430-440 JJ denotes anti-tumor
T9891 426-429 DT denotes the
T9890 423-425 TO denotes to
T9889 411-422 VB denotes contributes
T9888 405-410 NN denotes IL-10
T9887 401-404 DT denotes the
T9886 398-400 IN denotes by
T9885 392-397 NN denotes NF-κB
T9884 389-391 IN denotes of
T9883 378-388 NN denotes Inhibition
T9882 375-376 -RRB- denotes ]
T9881 373-375 CD denotes 45
T9880 372-373 -LRB- denotes [
T9879 367-371 FW denotes vivo
T9878 364-366 FW denotes in
T9877 360-363 CC denotes and
T9876 358-359 -RRB- denotes ]
T9875 356-358 CD denotes 44
T9874 355-356 -LRB- denotes [
T9855 252-254 IN denotes as
T9854 247-251 RB denotes well
T9853 244-246 RB denotes as
T9852 237-243 NN denotes factor
T9851 226-236 JJ denotes anti-tumor
T9850 223-225 DT denotes an
T10160 2020-2025 NN denotes study
T10159 2012-2019 JJ denotes present
T10158 2008-2011 DT denotes the
T10157 2005-2007 IN denotes in
T10156 1999-2004 NN denotes NF-κB
T10155 1996-1998 IN denotes of
T10154 1983-1995 NN denotes inactivation
T10153 1979-1982 DT denotes the
T10152 1971-1978 IN denotes through
T10151 1966-1970 NN denotes mice
T10150 1958-1965 NN denotes CCR5−/−
T10149 1955-1957 IN denotes of
T10148 1944-1954 NN denotes inhibition
T10147 1937-1943 NN denotes growth
T10146 1931-1936 NN denotes tumor
T10145 1927-1930 DT denotes the
T10144 1924-1926 IN denotes in
T10143 1915-1923 VB denotes involved
T10142 1904-1914 RB denotes critically
T10141 1901-1903 VB denotes be
T10140 1895-1900 MD denotes could
T10139 1888-1894 NN denotes IL-1Ra
T10138 1879-1887 VB denotes indicate
T10137 1874-1878 NN denotes data
T10136 1868-1873 DT denotes these
T10135 1866-1867 -COMMA- denotes ,
T10134 1858-1866 RB denotes together
T10133 1852-1857 VB denotes Taken
T10132 1845-1850 NN denotes cells
T10131 1836-1844 NN denotes melanoma
T10130 1832-1835 NN denotes B16
T10129 1827-1831 IN denotes with
T10128 1816-1826 VB denotes inoculated
T10127 1811-1815 NN denotes mice
T10126 1803-1810 NN denotes CCR5−/−
T10125 1800-1802 IN denotes of
T10124 1792-1799 NN denotes tissues
T10123 1786-1791 NN denotes tumor
T10122 1782-1785 DT denotes the
T10121 1779-1781 IN denotes in
T10120 1770-1778 VB denotes elevated
T10119 1756-1769 RB denotes significantly
T10118 1751-1755 VB denotes were
T10117 1744-1750 NN denotes IL-1Ra
T10116 1741-1743 IN denotes of
T10115 1734-1740 NN denotes levels
T10114 1730-1733 DT denotes the
T10113 1725-1729 IN denotes that
T10112 1719-1724 VB denotes found
T10111 1716-1718 PRP denotes We
T10110 1713-1714 -RRB- denotes ]
T10109 1711-1713 CD denotes 37
T10108 1710-1711 -LRB- denotes [
T10107 1701-1709 NN denotes pathways
T10106 1695-1700 NN denotes NF-κB
T10105 1686-1694 VB denotes blocking
T10104 1683-1685 IN denotes by
T10103 1677-1682 NN denotes cells
T10102 1670-1676 NN denotes Caco-2
T10101 1667-1669 IN denotes in
T10100 1656-1666 NN denotes production
T10099 1651-1655 NN denotes IL-8
T10098 1647-1650 CC denotes and
T10097 1642-1646 NN denotes IL-6
T10096 1633-1641 VB denotes inhibits
T10095 1631-1632 -RRB- denotes )
T10094 1623-1631 NN denotes icIL-1Ra
T10093 1622-1623 -LRB- denotes (
T10092 1615-1621 NN denotes IL-1Ra
T10091 1601-1614 JJ denotes Intracellular
T10090 1598-1599 -RRB- denotes ]
T9849 220-222 IN denotes as
T9848 214-219 VB denotes known
T9847 209-213 RB denotes well
T9846 206-208 VB denotes is
T9845 204-205 -RRB- denotes )
T9844 199-204 NN denotes IL-10
T9843 198-199 -LRB- denotes (
T9842 195-197 CD denotes 10
T9841 183-194 NN denotes interleukin
T9840 179-182 DT denotes The
T9839 176-177 -RRB- denotes ]
T9838 174-176 CD denotes 41
T9837 173-174 -LRB- denotes [
T9836 167-172 NN denotes cells
T9835 161-166 NN denotes tumor
T9834 158-160 IN denotes in
T9833 149-157 NN denotes pathways
T9832 143-148 NN denotes NF-κB
T9831 134-142 VB denotes activate
T9830 132-133 -COMMA- denotes ,
T9829 128-132 NN denotes IL-8
T9828 124-127 CC denotes and
T9827 119-123 NN denotes IL-6
T9826 117-118 -COMMA- denotes ,
T9825 113-117 NN denotes IL-1
T9824 103-112 VB denotes including
T9823 101-102 -COMMA- denotes ,
T9822 92-101 NN denotes cytokines
T9821 79-91 JJ denotes Inflammatory
T9820 72-77 NN denotes NF-κB
T9819 61-71 VB denotes regulating
T9818 58-60 IN denotes by
T9817 51-57 NN denotes growth
T9816 45-50 NN denotes tumor
T9815 38-44 VB denotes affect
T9814 29-37 NN denotes cytokine
T9813 24-28 IN denotes that
T9812 17-23 VB denotes showed
T9811 9-16 NN denotes studies
T9810 0-8 JJ denotes Numerous
T9873 349-354 FW denotes vitro
T9872 346-348 FW denotes in
T9871 341-345 CC denotes both
T9870 335-340 NN denotes NF-κB
T9869 325-334 VB denotes activated
T9868 310-324 RB denotes constitutively
T9867 301-309 VB denotes inhibits
T9866 295-300 NN denotes IL-10
T9865 292-293 -RRB- denotes ]
T9864 290-292 CD denotes 43
T9863 289-290 -LRB- denotes [
T9862 287-288 -COMMA- denotes ,
T9861 286-287 -RRB- denotes ]
T9860 284-286 CD denotes 42
T9859 283-284 -LRB- denotes [
T9858 276-282 NN denotes factor
T9857 258-275 JJ denotes anti-inflammatory
T9856 255-257 DT denotes an
R6366 T9811 T9810 arg1Of studies,Numerous
R6367 T9811 T9812 arg1Of studies,showed
R6368 T9814 T9815 arg1Of cytokine,affect
R6369 T9814 T9819 arg1Of cytokine,regulating
R6370 T9815 T9812 arg2Of affect,showed
R6371 T9815 T9813 arg1Of affect,that
R6372 T9815 T9818 arg1Of affect,by
R6373 T9817 T9815 arg2Of growth,affect
R6374 T9817 T9816 arg1Of growth,tumor
R6375 T9819 T9818 arg2Of regulating,by
R6376 T9820 T9819 arg2Of NF-κB,regulating
R6377 T9822 T9821 arg1Of cytokines,Inflammatory
R6378 T9822 T9823 arg1Of cytokines,","
R6379 T9822 T9824 arg1Of cytokines,including
R6380 T9822 T9831 arg1Of cytokines,activate
R6381 T9825 T9826 arg1Of IL-1,","
R6382 T9826 T9828 arg1Of ",",and
R6383 T9827 T9826 arg2Of IL-6,","
R6384 T9828 T9824 arg2Of and,including
R6385 T9829 T9828 arg2Of IL-8,and
R6386 T9831 T9830 arg1Of activate,","
R6387 T9833 T9831 arg2Of pathways,activate
R6388 T9833 T9832 arg1Of pathways,NF-κB
R6389 T9833 T9834 arg1Of pathways,in
R6390 T9836 T9834 arg2Of cells,in
R6391 T9836 T9835 arg1Of cells,tumor
R6392 T9836 T9837 arg1Of cells,[
R6393 T9838 T9837 arg2Of 41,[
R6394 T9839 T9837 arg3Of ],[
R6395 T9841 T9840 arg1Of interleukin,The
R6396 T9841 T9842 arg1Of interleukin,10
R6397 T9841 T9843 arg1Of interleukin,(
R6398 T9841 T9846 arg1Of interleukin,is
R6399 T9841 T9848 arg2Of interleukin,known
R6400 T9844 T9843 arg2Of IL-10,(
R6401 T9845 T9843 arg3Of ),(
R6402 T9848 T9846 arg2Of known,is
R6403 T9848 T9847 arg1Of known,well
R6404 T9848 T9849 arg1Of known,as
R6405 T9848 T9862 arg1Of known,","
R6406 T9848 T9863 arg1Of known,[
R6407 T9852 T9850 arg1Of factor,an
R6408 T9852 T9851 arg1Of factor,anti-tumor
R6409 T9852 T9855 arg1Of factor,as
R6410 T9855 T9849 arg2Of as,as
R6411 T9855 T9853 arg1Of as,as
R6412 T9855 T9854 arg1Of as,well
R6413 T9858 T9855 arg2Of factor,as
R6414 T9858 T9856 arg1Of factor,an
R6415 T9858 T9857 arg1Of factor,anti-inflammatory
R6416 T9858 T9859 arg1Of factor,[
R6417 T9860 T9859 arg2Of 42,[
R6418 T9861 T9859 arg3Of ],[
R6419 T9864 T9863 arg2Of 43,[
R6420 T9865 T9863 arg3Of ],[
R6421 T9866 T9867 arg1Of IL-10,inhibits
R6422 T9867 T9868 arg1Of inhibits,constitutively
R6423 T9867 T9880 arg1Of inhibits,[
R6424 T9870 T9867 arg2Of NF-κB,inhibits
R6425 T9870 T9869 arg2Of NF-κB,activated
R6426 T9870 T9873 arg1Of NF-κB,vitro
R6427 T9870 T9874 arg1Of NF-κB,[
R6428 T9870 T9879 arg1Of NF-κB,vivo
R6429 T9873 T9871 arg1Of vitro,both
R6430 T9873 T9872 arg1Of vitro,in
R6431 T9875 T9874 arg2Of 44,[
R6432 T9876 T9874 arg3Of ],[
R6433 T9879 T9877 arg1Of vivo,and
R6434 T9879 T9878 arg1Of vivo,in
R6435 T9881 T9880 arg2Of 45,[
R6436 T9882 T9880 arg3Of ],[
R6437 T9883 T9884 arg1Of Inhibition,of
R6438 T9883 T9886 arg1Of Inhibition,by
R6439 T9883 T9889 arg1Of Inhibition,contributes
R6440 T9885 T9884 arg2Of NF-κB,of
R6441 T9888 T9886 arg2Of IL-10,by
R6442 T9888 T9887 arg1Of IL-10,the
R6443 T9889 T9890 arg1Of contributes,to
R6444 T9889 T9894 arg1Of contributes,through
R6445 T9889 T9904 arg1Of contributes,[
R6446 T9893 T9890 arg2Of effects,to
R6447 T9893 T9891 arg1Of effects,the
R6448 T9893 T9892 arg1Of effects,anti-tumor
R6449 T9896 T9894 arg2Of activation,through
R6450 T9896 T9895 arg1Of activation,the
R6451 T9896 T9897 arg1Of activation,of
R6452 T9896 T9901 arg1Of activation,in
R6453 T9898 T9899 arg1Of caspase-3,and
R6454 T9899 T9897 arg2Of and,of
R6455 T9900 T9899 arg2Of apoptosis,and
R6456 T9903 T9901 arg2Of mice,in
R6457 T9903 T9902 arg1Of mice,Colon26-bearing
R6458 T9905 T9904 arg2Of 43,[
R6459 T9906 T9904 arg3Of ],[
R6460 T9910 T9909 arg1Of studies,several
R6461 T9910 T9911 arg1Of studies,have
R6462 T9910 T9912 arg1Of studies,demonstrated
R6463 T9912 T9907 arg1Of demonstrated,Similarly
R6464 T9912 T9908 arg1Of demonstrated,","
R6465 T9912 T9911 arg2Of demonstrated,have
R6466 T9914 T9912 arg2Of ability,demonstrated
R6467 T9914 T9913 arg1Of ability,the
R6468 T9914 T9915 arg1Of ability,of
R6469 T9914 T9917 modOf ability,to
R6470 T9916 T9915 arg2Of IL-1Ra,of
R6471 T9918 T9917 arg1Of abrogate,to
R6472 T9921 T9918 arg2Of effects,abrogate
R6473 T9921 T9919 arg1Of effects,the
R6474 T9921 T9920 arg1Of effects,proinflammatory
R6475 T9921 T9922 arg1Of effects,of
R6476 T9923 T9922 arg2Of IL-1,of
R6477 T9923 T9924 arg1Of IL-1,[
R6478 T9925 T9924 arg2Of 46,[
R6479 T9926 T9924 arg3Of ],[
R6480 T9927 T9928 arg1Of It,has
R6481 T9927 T9929 arg1Of It,been
R6482 T9927 T9930 arg2Of It,reported
R6483 T9930 T9928 arg2Of reported,has
R6484 T9930 T9929 arg2Of reported,been
R6485 T9932 T9933 arg1Of IL-1,induces
R6486 T9932 T9943 arg1Of IL-1,increases
R6487 T9933 T9938 arg1Of induces,in
R6488 T9933 T9942 arg1Of induces,and
R6489 T9935 T9933 arg2Of activation,induces
R6490 T9935 T9934 arg1Of activation,the
R6491 T9935 T9936 arg1Of activation,of
R6492 T9937 T9936 arg2Of NF-κB,of
R6493 T9940 T9938 arg2Of cancers,in
R6494 T9940 T9939 arg1Of cancers,several
R6495 T9942 T9930 arg3Of and,reported
R6496 T9942 T9931 arg1Of and,that
R6497 T9942 T9941 arg1Of and,","
R6498 T9943 T9942 arg2Of increases,and
R6499 T9946 T9944 arg1Of progression,cell
R6500 T9946 T9945 arg1Of progression,cycle
R6501 T9946 T9948 arg1Of progression,and
R6502 T9948 T9943 arg2Of and,increases
R6503 T9948 T9947 arg1Of and,","
R6504 T9950 T9948 arg2Of suppression,and
R6505 T9950 T9949 arg1Of suppression,the
R6506 T9950 T9951 arg1Of suppression,of
R6507 T9950 T9955 arg1Of suppression,leading
R6508 T9954 T9951 arg2Of death,of
R6509 T9954 T9952 arg1Of death,apoptotic
R6510 T9954 T9953 arg1Of death,cell
R6511 T9955 T9956 arg1Of leading,to
R6512 T9958 T9956 arg2Of promotion,to
R6513 T9958 T9957 arg1Of promotion,tumor
R6514 T9960 T9959 arg1Of results,The
R6515 T9960 T9961 arg1Of results,of
R6516 T9960 T9964 arg1Of results,over
R6517 T9960 T9969 arg1Of results,indicate
R6518 T9963 T9961 arg2Of studies,of
R6519 T9963 T9962 arg1Of studies,various
R6520 T9968 T9964 arg2Of years,over
R6521 T9968 T9965 arg1Of years,the
R6522 T9968 T9966 arg1Of years,past
R6523 T9968 T9967 arg1Of years,10
R6524 T9973 T9971 arg1Of function,the
R6525 T9973 T9972 arg1Of function,major
R6526 T9973 T9974 arg1Of function,of
R6527 T9973 T9976 arg1Of function,is
R6528 T9975 T9974 arg2Of IL-1Ra,of
R6529 T9976 T9969 arg2Of is,indicate
R6530 T9976 T9970 arg1Of is,that
R6531 T9978 T9976 arg2Of regulate,is
R6532 T9978 T9977 arg1Of regulate,to
R6533 T9978 T9984 arg1Of regulate,by
R6534 T9981 T9978 arg2Of effects,regulate
R6535 T9981 T9979 arg1Of effects,the
R6536 T9981 T9980 arg1Of effects,pleiotropic
R6537 T9981 T9982 arg1Of effects,of
R6538 T9983 T9982 arg2Of IL-1,of
R6539 T9986 T9984 arg2Of blocking,by
R6540 T9986 T9985 arg1Of blocking,competitively
R6541 T9988 T9986 arg2Of functions,blocking
R6542 T9988 T9987 arg1Of functions,its
R6543 T9988 T9989 arg1Of functions,[
R6544 T9990 T9989 arg2Of 47,[
R6545 T9991 T9989 arg3Of ],[
R6546 T9993 T9992 arg1Of ability,The
R6547 T9993 T9994 arg1Of ability,of
R6548 T9993 T9996 modOf ability,to
R6549 T9993 T10001 arg1Of ability,is
R6550 T9993 T10002 arg1Of ability,of
R6551 T9995 T9994 arg2Of IL-1,of
R6552 T9997 T9996 arg1Of induce,to
R6553 T10000 T9997 arg2Of antagonist,induce
R6554 T10000 T9998 arg1Of antagonist,its
R6555 T10000 T9999 arg1Of antagonist,own
R6556 T10002 T10001 arg2Of of,is
R6557 T10003 T10002 arg2Of interest,of
R6558 T10003 T10004 arg1Of interest,in
R6559 T10005 T10004 arg2Of understanding,in
R6560 T10007 T10008 arg1Of regulation,and
R6561 T10008 T10005 arg2Of and,understanding
R6562 T10008 T10006 arg1Of and,the
R6563 T10008 T10010 arg1Of and,of
R6564 T10008 T10013 arg1Of and,in
R6565 T10009 T10008 arg2Of dysregulation,and
R6566 T10012 T10010 arg2Of signaling,of
R6567 T10012 T10011 arg1Of signaling,IL-1
R6568 T10014 T10015 arg1Of normal,and
R6569 T10016 T10015 arg2Of diseased,and
R6570 T10017 T10013 arg2Of tissue,in
R6571 T10017 T10014 arg1Of tissue,normal
R6572 T10017 T10016 arg1Of tissue,diseased
R6573 T10018 T10019 arg1Of Up-regulation,of
R6574 T10018 T10023 arg1Of Up-regulation,represents
R6575 T10022 T10019 arg2Of antagonist,of
R6576 T10022 T10020 arg1Of antagonist,the
R6577 T10022 T10021 arg1Of antagonist,receptor
R6578 T10025 T10023 arg2Of mechanism,represents
R6579 T10025 T10024 arg1Of mechanism,a
R6580 T10025 T10026 arg1Of mechanism,for
R6581 T10027 T10028 arg1Of turning,off
R6582 T10027 T10031 arg1Of turning,and
R6583 T10030 T10027 arg2Of signaling,turning
R6584 T10030 T10029 arg1Of signaling,IL-1
R6585 T10031 T10026 arg2Of and,for
R6586 T10032 T10031 arg2Of creating,and
R6587 T10035 T10032 arg2Of state,creating
R6588 T10035 T10033 arg1Of state,a
R6589 T10035 T10034 arg1Of state,temporary
R6590 T10035 T10036 arg1Of state,of
R6591 T10037 T10036 arg2Of refractoriness,of
R6592 T10040 T10038 arg1Of expression,The
R6593 T10040 T10039 arg2Of expression,elevated
R6594 T10040 T10041 arg1Of expression,of
R6595 T10040 T10043 arg1Of expression,","
R6596 T10040 T10044 arg1Of expression,without
R6597 T10040 T10052 arg1Of expression,suggests
R6598 T10042 T10041 arg2Of IL-1Ra,of
R6599 T10046 T10044 arg2Of change,without
R6600 T10046 T10045 arg1Of change,any
R6601 T10046 T10047 arg1Of change,of
R6602 T10046 T10049 arg1Of change,in
R6603 T10048 T10047 arg2Of IL-1,of
R6604 T10050 T10049 arg2Of tumors,in
R6605 T10052 T10051 arg1Of suggests,","
R6606 T10056 T10054 arg1Of system,the
R6607 T10056 T10055 arg1Of system,IL-1-signaling
R6608 T10056 T10057 arg1Of system,may
R6609 T10056 T10058 arg1Of system,be
R6610 T10056 T10059 arg2Of system,dysregulated
R6611 T10059 T10052 arg2Of dysregulated,suggests
R6612 T10059 T10053 arg1Of dysregulated,that
R6613 T10059 T10057 arg2Of dysregulated,may
R6614 T10059 T10058 arg2Of dysregulated,be
R6615 T10059 T10062 arg1Of dysregulated,in
R6616 T10061 T10059 arg1Of IL-1Ra,dysregulated
R6617 T10061 T10060 arg2Of IL-1Ra,by
R6618 T10063 T10062 arg2Of tumors,in
R6619 T10064 T10065 arg1Of IL-1Ra,has
R6620 T10064 T10066 arg1Of IL-1Ra,been
R6621 T10064 T10067 arg2Of IL-1Ra,shown
R6622 T10064 T10069 arg1Of IL-1Ra,inhibit
R6623 T10067 T10065 arg2Of shown,has
R6624 T10067 T10066 arg2Of shown,been
R6625 T10069 T10067 arg3Of inhibit,shown
R6626 T10069 T10068 arg1Of inhibit,to
R6627 T10069 T10080 arg1Of inhibit,[
R6628 T10069 T10083 arg1Of inhibit,","
R6629 T10069 T10084 arg1Of inhibit,[
R6630 T10069 T10087 arg1Of inhibit,","
R6631 T10069 T10088 arg1Of inhibit,[
R6632 T10071 T10069 arg2Of progression,inhibit
R6633 T10071 T10070 arg1Of progression,tumor
R6634 T10071 T10072 arg1Of progression,in
R6635 T10073 T10074 arg1Of prostate,","
R6636 T10074 T10077 arg1Of ",",and
R6637 T10075 T10074 arg2Of breast,","
R6638 T10077 T10072 arg2Of and,in
R6639 T10077 T10076 arg1Of and,","
R6640 T10079 T10077 arg2Of cancer,and
R6641 T10079 T10078 arg1Of cancer,skin
R6642 T10081 T10080 arg2Of 14,[
R6643 T10082 T10080 arg3Of ],[
R6644 T10085 T10084 arg2Of 15,[
R6645 T10086 T10084 arg3Of ],[
R6646 T10089 T10088 arg2Of 16,[
R6647 T10090 T10088 arg3Of ],[
R6648 T10092 T10091 arg1Of IL-1Ra,Intracellular
R6649 T10092 T10093 arg1Of IL-1Ra,(
R6650 T10092 T10096 arg1Of IL-1Ra,inhibits
R6651 T10092 T10105 arg1Of IL-1Ra,blocking
R6652 T10094 T10093 arg2Of icIL-1Ra,(
R6653 T10095 T10093 arg3Of ),(
R6654 T10096 T10104 arg1Of inhibits,by
R6655 T10097 T10098 arg1Of IL-6,and
R6656 T10099 T10098 arg2Of IL-8,and
R6657 T10100 T10096 arg2Of production,inhibits
R6658 T10100 T10097 arg1Of production,IL-6
R6659 T10100 T10099 arg1Of production,IL-8
R6660 T10100 T10101 arg1Of production,in
R6661 T10103 T10101 arg2Of cells,in
R6662 T10103 T10102 arg1Of cells,Caco-2
R6663 T10105 T10104 arg2Of blocking,by
R6664 T10107 T10105 arg2Of pathways,blocking
R6665 T10107 T10106 arg1Of pathways,NF-κB
R6666 T10107 T10108 arg1Of pathways,[
R6667 T10109 T10108 arg2Of 37,[
R6668 T10110 T10108 arg3Of ],[
R6669 T10111 T10112 arg1Of We,found
R6670 T10115 T10114 arg1Of levels,the
R6671 T10115 T10116 arg1Of levels,of
R6672 T10115 T10118 arg1Of levels,were
R6673 T10115 T10120 arg2Of levels,elevated
R6674 T10117 T10116 arg2Of IL-1Ra,of
R6675 T10120 T10112 arg2Of elevated,found
R6676 T10120 T10113 arg1Of elevated,that
R6677 T10120 T10118 arg2Of elevated,were
R6678 T10120 T10119 arg1Of elevated,significantly
R6679 T10120 T10121 arg1Of elevated,in
R6680 T10124 T10121 arg2Of tissues,in
R6681 T10124 T10122 arg1Of tissues,the
R6682 T10124 T10123 arg1Of tissues,tumor
R6683 T10124 T10125 arg1Of tissues,of
R6684 T10127 T10125 arg2Of mice,of
R6685 T10127 T10126 arg1Of mice,CCR5−/−
R6686 T10127 T10128 arg2Of mice,inoculated
R6687 T10128 T10129 arg1Of inoculated,with
R6688 T10132 T10129 arg2Of cells,with
R6689 T10132 T10130 arg1Of cells,B16
R6690 T10132 T10131 arg1Of cells,melanoma
R6691 T10133 T10134 arg1Of Taken,together
R6692 T10137 T10136 arg1Of data,these
R6693 T10137 T10138 arg1Of data,indicate
R6694 T10138 T10133 modOf indicate,Taken
R6695 T10138 T10135 arg1Of indicate,","
R6696 T10139 T10140 arg1Of IL-1Ra,could
R6697 T10139 T10141 arg1Of IL-1Ra,be
R6698 T10139 T10143 arg2Of IL-1Ra,involved
R6699 T10143 T10138 arg2Of involved,indicate
R6700 T10143 T10140 arg2Of involved,could
R6701 T10143 T10141 arg2Of involved,be
R6702 T10143 T10142 arg1Of involved,critically
R6703 T10143 T10144 arg1Of involved,in
R6704 T10143 T10152 arg1Of involved,through
R6705 T10148 T10144 arg2Of inhibition,in
R6706 T10148 T10145 arg1Of inhibition,the
R6707 T10148 T10146 arg1Of inhibition,tumor
R6708 T10148 T10147 arg1Of inhibition,growth
R6709 T10148 T10149 arg1Of inhibition,of
R6710 T10151 T10149 arg2Of mice,of
R6711 T10151 T10150 arg1Of mice,CCR5−/−
R6712 T10154 T10152 arg2Of inactivation,through
R6713 T10154 T10153 arg1Of inactivation,the
R6714 T10154 T10155 arg1Of inactivation,of
R6715 T10154 T10157 arg1Of inactivation,in
R6716 T10156 T10155 arg2Of NF-κB,of
R6717 T10160 T10157 arg2Of study,in
R6718 T10160 T10158 arg1Of study,the
R6719 T10160 T10159 arg1Of study,present

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T9187 1958-1962 Protein denotes CCR5
T9186 1888-1894 Protein denotes IL-1Ra
T9185 1803-1807 Protein denotes CCR5
T9184 1744-1750 Protein denotes IL-1Ra
T9183 1642-1646 Protein denotes IL-6
T9182 1623-1631 Protein denotes icIL-1Ra
T9181 1601-1621 Protein denotes Intracellular IL-1Ra
T9180 1477-1483 Protein denotes IL-1Ra
T9179 1368-1374 Protein denotes IL-1Ra
T9178 933-939 Protein denotes IL-1Ra
T9177 589-595 Protein denotes IL-1Ra
T9176 405-410 Protein denotes IL-10
T9175 295-300 Protein denotes IL-10
T9174 199-204 Protein denotes IL-10
T9173 183-197 Protein denotes interleukin 10
T9172 119-123 Protein denotes IL-6

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T10937 405-410 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T10936 295-300 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T10935 195-201 http://www.uniprot.org/uniprot/P22301 denotes 10 (IL
T10934 1651-1655 http://www.uniprot.org/uniprot/P10145 denotes IL-8
T10933 128-132 http://www.uniprot.org/uniprot/P10145 denotes IL-8
T10931 1642-1646 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T10930 119-123 http://www.uniprot.org/uniprot/P05231 denotes IL-6
T10922 475-484 http://www.uniprot.org/uniprot/P42574 denotes caspase-3
T10913 1888-1894 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10912 1744-1750 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10911 1615-1621 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10910 1495-1501 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10909 1477-1483 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10908 1368-1374 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10907 933-939 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10906 589-595 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T10881 1958-1962 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T10880 1803-1807 http://www.uniprot.org/uniprot/P51681 denotes CCR5

UBERON-AE

Id Subject Object Predicate Lexical cue
T9009 1559-1565 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T9004 1792-1799 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
T9003 1188-1194 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue

GO-BP

Id Subject Object Predicate Lexical cue
T9273 1651-1666 http://purl.obolibrary.org/obo/GO_0032637 denotes IL-8 production
T9272 1651-1666 http://purl.obolibrary.org/obo/GO_0032677 denotes IL-8 production
T9270 1437-1446 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T9269 1281-1290 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T9268 1155-1164 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T9267 1199-1209 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T9266 1118-1128 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T9265 747-769 http://purl.obolibrary.org/obo/GO_0051726 denotes cell cycle progression
T9264 747-769 http://purl.obolibrary.org/obo/GO_0007050 denotes cell cycle progression
T9263 747-757 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T9262 489-498 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T9261 794-814 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptotic cell death
T9260 489-498 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T9259 461-482 http://purl.obolibrary.org/obo/GO_0006919 denotes activation of caspase
T9256 809-814 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T9253 804-814 http://purl.obolibrary.org/obo/GO_0008219 denotes cell death
T9241 693-712 http://purl.obolibrary.org/obo/GO_0051092 denotes activation of NF-κB
T9240 325-340 http://purl.obolibrary.org/obo/GO_0051092 denotes activated NF-κB
T9236 1937-1954 http://purl.obolibrary.org/obo/GO_0045926 denotes growth inhibition
T9226 1937-1943 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9225 51-57 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

GO-MF

Id Subject Object Predicate Lexical cue
T9332 295-300 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T9331 195-201 http://purl.obolibrary.org/obo/GO_0005141 denotes 10 (IL
T9333 405-410 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T9330 1651-1655 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8
T9329 128-132 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8
T9327 1642-1646 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T9326 119-123 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6
T9325 1432-1436 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T9324 1398-1402 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T9323 1276-1280 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T9322 1150-1154 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T9321 1048-1052 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T9320 982-986 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T9319 676-680 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T9318 639-643 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T9317 113-117 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1

GO-CC

Id Subject Object Predicate Lexical cue
T9293 1677-1682 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9292 167-172 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9294 1845-1850 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T9312 1601-1614 http://purl.obolibrary.org/obo/GO_0005622 denotes Intracellular

sentences

Id Subject Object Predicate Lexical cue
T9036 1852-2026 Sentence denotes Taken together, these data indicate IL-1Ra could be critically involved in the tumor growth inhibition of CCR5−/− mice through the inactivation of NF-κB in the present study.
T9035 1716-1851 Sentence denotes We found that the levels of IL-1Ra were significantly elevated in the tumor tissues of CCR5−/− mice inoculated with B16 melanoma cells.
T9034 1601-1715 Sentence denotes Intracellular IL-1Ra (icIL-1Ra) inhibits IL-6 and IL-8 production in Caco-2 cells by blocking NF-κB pathways [37].
T9033 1495-1600 Sentence denotes IL-1Ra has been shown to inhibit tumor progression in prostate, breast, and skin cancer [14], [15], [16].
T9032 1341-1494 Sentence denotes The elevated expression of IL-1Ra, without any change of IL-1 in tumors, suggests that the IL-1-signaling system may be dysregulated by IL-1Ra in tumors.
T9031 1196-1340 Sentence denotes Up-regulation of the receptor antagonist represents a mechanism for turning off IL-1 signaling and creating a temporary state of refractoriness.
T9030 1033-1195 Sentence denotes The ability of IL-1 to induce its own antagonist is of interest in understanding the regulation and dysregulation of IL-1 signaling in normal and diseased tissue.
T9029 843-1032 Sentence denotes The results of various studies over the past 10 years indicate that the major function of IL-1Ra is to regulate the pleiotropic effects of IL-1 by competitively blocking its functions [47].
T9028 650-842 Sentence denotes It has been reported that IL-1 induces the activation of NF-κB in several cancers, and increases cell cycle progression, and the suppression of apoptotic cell death leading to tumor promotion.
T9027 529-649 Sentence denotes Similarly, several studies have demonstrated the ability of IL-1Ra to abrogate the proinflammatory effects of IL-1 [46].
T9026 378-528 Sentence denotes Inhibition of NF-κB by the IL-10 contributes to the anti-tumor effects through the activation of caspase-3 and apoptosis in Colon26-bearing mice [43].
T9025 295-377 Sentence denotes IL-10 inhibits constitutively activated NF-κB both in vitro [44] and in vivo [45].
T9024 179-294 Sentence denotes The interleukin 10 (IL-10) is well known as an anti-tumor factor as well as an anti-inflammatory factor [42], [43].
T9023 79-178 Sentence denotes Inflammatory cytokines, including IL-1, IL-6 and IL-8, activate NF-κB pathways in tumor cells [41].
T9022 0-78 Sentence denotes Numerous studies showed that cytokine affect tumor growth by regulating NF-κB.
T164 0-78 Sentence denotes Numerous studies showed that cytokine affect tumor growth by regulating NF-κB.
T165 79-178 Sentence denotes Inflammatory cytokines, including IL-1, IL-6 and IL-8, activate NF-κB pathways in tumor cells [41].
T166 179-294 Sentence denotes The interleukin 10 (IL-10) is well known as an anti-tumor factor as well as an anti-inflammatory factor [42], [43].
T167 295-377 Sentence denotes IL-10 inhibits constitutively activated NF-κB both in vitro [44] and in vivo [45].
T168 378-528 Sentence denotes Inhibition of NF-κB by the IL-10 contributes to the anti-tumor effects through the activation of caspase-3 and apoptosis in Colon26-bearing mice [43].
T169 529-649 Sentence denotes Similarly, several studies have demonstrated the ability of IL-1Ra to abrogate the proinflammatory effects of IL-1 [46].
T170 650-842 Sentence denotes It has been reported that IL-1 induces the activation of NF-κB in several cancers, and increases cell cycle progression, and the suppression of apoptotic cell death leading to tumor promotion.
T171 843-1032 Sentence denotes The results of various studies over the past 10 years indicate that the major function of IL-1Ra is to regulate the pleiotropic effects of IL-1 by competitively blocking its functions [47].
T172 1033-1195 Sentence denotes The ability of IL-1 to induce its own antagonist is of interest in understanding the regulation and dysregulation of IL-1 signaling in normal and diseased tissue.
T173 1196-1340 Sentence denotes Up-regulation of the receptor antagonist represents a mechanism for turning off IL-1 signaling and creating a temporary state of refractoriness.
T174 1341-1494 Sentence denotes The elevated expression of IL-1Ra, without any change of IL-1 in tumors, suggests that the IL-1-signaling system may be dysregulated by IL-1Ra in tumors.
T175 1495-1600 Sentence denotes IL-1Ra has been shown to inhibit tumor progression in prostate, breast, and skin cancer [14], [15], [16].
T176 1601-1715 Sentence denotes Intracellular IL-1Ra (icIL-1Ra) inhibits IL-6 and IL-8 production in Caco-2 cells by blocking NF-κB pathways [37].
T177 1716-1851 Sentence denotes We found that the levels of IL-1Ra were significantly elevated in the tumor tissues of CCR5−/− mice inoculated with B16 melanoma cells.
T178 1852-2026 Sentence denotes Taken together, these data indicate IL-1Ra could be critically involved in the tumor growth inhibition of CCR5−/− mice through the inactivation of NF-κB in the present study.

simple1

Id Subject Object Predicate Lexical cue
T9380 1958-1962 Protein denotes CCR5
T9379 1888-1894 Protein denotes IL-1Ra
T9378 1803-1807 Protein denotes CCR5
T9377 1744-1750 Protein denotes IL-1Ra
T9376 1642-1646 Protein denotes IL-6
T9375 1623-1631 Protein denotes icIL-1Ra
T9374 1601-1621 Protein denotes Intracellular IL-1Ra
T9373 1477-1483 Protein denotes IL-1Ra
T9372 1368-1374 Protein denotes IL-1Ra
T9371 933-939 Protein denotes IL-1Ra
T9370 589-595 Protein denotes IL-1Ra
T9369 405-410 Protein denotes IL-10
T9368 295-300 Protein denotes IL-10
T9367 199-204 Protein denotes IL-10
T9366 183-197 Protein denotes interleukin 10
T9365 119-123 Protein denotes IL-6

DLUT931

Id Subject Object Predicate Lexical cue
T11017 1770-1778 Positive_regulation denotes elevated
T11016 1633-1641 Negative_regulation denotes inhibits
T11015 1656-1666 Gene_expression denotes production
T11014 1345-1353 Positive_regulation denotes elevated
T11013 1354-1364 Gene_expression denotes expression
T11012 378-388 Negative_regulation denotes Inhibition
T10969 1958-1962 Protein denotes CCR5
T10968 1888-1894 Protein denotes IL-1Ra
T10967 1803-1807 Protein denotes CCR5
T10966 1744-1750 Protein denotes IL-1Ra
T10965 1642-1646 Protein denotes IL-6
T10964 1623-1631 Protein denotes icIL-1Ra
T10963 1601-1621 Protein denotes Intracellular IL-1Ra
T10962 1477-1483 Protein denotes IL-1Ra
T10961 1368-1374 Protein denotes IL-1Ra
T10960 933-939 Protein denotes IL-1Ra
T10959 589-595 Protein denotes IL-1Ra
T10958 405-410 Protein denotes IL-10
T10957 295-300 Protein denotes IL-10
T10956 199-204 Protein denotes IL-10
T10955 183-197 Protein denotes interleukin 10
T10954 119-123 Protein denotes IL-6
R7344 T10958 T11012 themeOf IL-10,Inhibition
R7346 T11013 T11014 themeOf expression,elevated
R7347 T10961 T11013 themeOf IL-1Ra,expression
R7348 T10964 T11016 causeOf icIL-1Ra,inhibits
R7349 T11015 T11016 themeOf production,inhibits
R7350 T10965 T11015 themeOf IL-6,production
R7351 T10966 T11017 themeOf IL-1Ra,elevated

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T11674 1276-1290 Positive_regulation denotes IL-1 signaling
T11673 1133-1164 Negative_regulation denotes dysregulation of IL-1 signaling
T11670 325-340 Positive_regulation denotes activated NF-κB
T11662 1071-1081 Entity denotes antagonist
T11661 1217-1225 Protein denotes receptor
T11659 119-123 Protein denotes IL-6
T11658 113-117 Protein denotes IL-1
T11657 325-340 Protein denotes activated NF-κB
T11656 1996-2004 Protein denotes of NF-κB
T11655 475-484 Protein denotes caspase-3
T11654 676-680 Protein denotes IL-1
T11651 1744-1750 Protein denotes IL-1Ra
T11650 255-293 Entity denotes an anti-inflammatory factor [42], [43]
T11644 1395-1402 Protein denotes of IL-1
T11642 1966-1970 Protein denotes mice
T11637 389-397 Protein denotes of NF-κB
T11629 704-712 Protein denotes of NF-κB
T11624 143-177 Protein denotes NF-κB pathways in tumor cells [41]
T11623 1210-1236 Entity denotes of the receptor antagonist
T11618 1428-1446 Protein denotes the IL-1-signaling
T11610 92-133 Protein denotes cytokines, including IL-1, IL-6 and IL-8,
T11602 1365-1374 Protein denotes of IL-1Ra
T11598 398-410 Protein denotes by the IL-10
T11587 930-939 Protein denotes of IL-1Ra
T11586 29-37 Protein denotes cytokine
T11571 1888-1894 Protein denotes IL-1Ra
T11569 1150-1154 Protein denotes IL-1
T11566 1832-1850 Entity denotes B16 melanoma cells
T11564 72-77 Protein denotes NF-κB
T11553 1474-1483 Protein denotes by IL-1Ra
T11551 586-595 Protein denotes of IL-1Ra
T11546 502-527 Protein denotes Colon26-bearing mice [43]
T11543 639-648 Protein denotes IL-1 [46]
T11541 128-132 Protein denotes IL-8
T11536 179-205 Protein denotes The interleukin 10 (IL-10)
T11529 161-177 Entity denotes tumor cells [41]
T11527 1642-1646 Protein denotes IL-6
T11524 295-300 Protein denotes IL-10
T11519 982-986 Protein denotes IL-1
T11517 1811-1815 Protein denotes mice
T11515 1601-1632 Protein denotes Intracellular IL-1Ra (icIL-1Ra)
T11511 1651-1655 Protein denotes IL-8
T11506 1623-1631 Protein denotes icIL-1Ra
T11502 1495-1501 Protein denotes IL-1Ra
T11501 1045-1052 Protein denotes of IL-1
T11500 199-204 Protein denotes IL-10
T11499 1276-1280 Protein denotes IL-1
T11695 1651-1666 Gene_expression denotes IL-8 production
T11690 689-712 Positive_regulation denotes the activation of NF-κB
T11687 676-769 Positive_regulation denotes IL-1 induces the activation of NF-κB in several cancers, and increases cell cycle progression
T11684 61-77 Regulation denotes regulating NF-κB
T11683 378-410 Negative_regulation denotes Inhibition of NF-κB by the IL-10
T11682 1979-2025 Negative_regulation denotes the inactivation of NF-κB in the present study
T11680 1341-1402 Gene_expression denotes The elevated expression of IL-1Ra, without any change of IL-1
T11679 1147-1164 Positive_regulation denotes of IL-1 signaling
R7549 T11499 T11674 causeOf IL-1,IL-1 signaling
R7557 T11511 T11695 themeOf IL-8,IL-8 production
R7563 T11629 T11690 themeOf of NF-κB,the activation of NF-κB
R7568 T11637 T11683 themeOf of NF-κB,Inhibition of NF-κB by the IL-10
R7570 T11564 T11684 themeOf NF-κB,regulating NF-κB
R7571 T11569 T11679 causeOf IL-1,of IL-1 signaling
R7572 T11654 T11687 causeOf IL-1,"IL-1 induces the activation of NF-κB in several cancers, and increases cell cycle progression"
R7574 T11656 T11682 themeOf of NF-κB,the inactivation of NF-κB in the present study
R7575 T11657 T11670 themeOf activated NF-κB,activated NF-κB
R7578 T11679 T11673 themeOf of IL-1 signaling,dysregulation of IL-1 signaling
R7579 T11598 T11683 causeOf by the IL-10,Inhibition of NF-κB by the IL-10
R7582 T11602 T11680 themeOf of IL-1Ra,"The elevated expression of IL-1Ra, without any change of IL-1"

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T12506 2025-2026 . denotes .
T12505 2020-2025 NN denotes study
T12504 2012-2019 JJ denotes present
T12503 2008-2011 DT denotes the
T12502 2005-2007 IN denotes in
T12501 1999-2004 NN denotes NF-κB
T12500 1996-1998 IN denotes of
T12499 1983-1995 NN denotes inactivation
T12498 1979-1982 DT denotes the
T12497 1971-1978 IN denotes through
T12496 1966-1970 NNS denotes mice
T12495 1964-1965 NN denotes −
T12494 1963-1964 NN denotes /
T12493 1962-1963 CD denotes −
T12492 1958-1962 CD denotes CCR5
T12491 1955-1957 IN denotes of
T12490 1944-1954 NN denotes inhibition
T12489 1937-1943 NN denotes growth
T12488 1931-1936 NN denotes tumor
T12487 1927-1930 DT denotes the
T12486 1924-1926 IN denotes in
T12485 1915-1923 VBN denotes involved
T12484 1904-1914 RB denotes critically
T12483 1901-1903 VB denotes be
T12482 1895-1900 MD denotes could
T12481 1888-1894 NN denotes IL-1Ra
T12480 1879-1887 VBP denotes indicate
T12479 1874-1878 NNS denotes data
T12478 1868-1873 DT denotes these
T12477 1866-1867 , denotes ,
T12476 1858-1866 RB denotes together
T12475 1852-1857 VBN denotes Taken
T12474 1850-1851 . denotes .
T12473 1845-1850 NNS denotes cells
T12472 1836-1844 NN denotes melanoma
T12471 1832-1835 NNP denotes B16
T12470 1827-1831 IN denotes with
T12469 1816-1826 VBN denotes inoculated
T12468 1811-1815 NNS denotes mice
T12467 1809-1810 NN denotes −
T12466 1808-1809 NN denotes /
T12465 1807-1808 CD denotes −
T12464 1803-1807 CD denotes CCR5
T12463 1800-1802 IN denotes of
T12462 1792-1799 NNS denotes tissues
T12461 1786-1791 NN denotes tumor
T12460 1782-1785 DT denotes the
T12459 1779-1781 IN denotes in
T12458 1770-1778 VBN denotes elevated
T12457 1756-1769 RB denotes significantly
T12456 1751-1755 VBD denotes were
T12455 1744-1750 NN denotes IL-1Ra
T12454 1741-1743 IN denotes of
T12453 1734-1740 NNS denotes levels
T12452 1730-1733 DT denotes the
T12451 1725-1729 IN denotes that
T12450 1719-1724 VBD denotes found
T12449 1716-1718 PRP denotes We
T12448 1714-1715 . denotes .
T12447 1713-1714 NNP denotes ]
T12446 1711-1713 CD denotes 37
T12445 1710-1711 NNP denotes [
T12444 1701-1709 NNS denotes pathways
T12443 1695-1700 JJ denotes NF-κB
T12442 1686-1694 VBG denotes blocking
T12441 1683-1685 IN denotes by
T12440 1677-1682 NNS denotes cells
T12439 1670-1676 JJ denotes Caco-2
T12438 1667-1669 IN denotes in
T12437 1656-1666 NN denotes production
T12436 1651-1655 JJ denotes IL-8
T12435 1647-1650 CC denotes and
T12434 1642-1646 NNP denotes IL-6
T12433 1633-1641 VBZ denotes inhibits
T12432 1631-1632 -RRB- denotes )
T12431 1623-1631 NN denotes icIL-1Ra
T12430 1622-1623 -LRB- denotes (
T12429 1615-1621 NN denotes IL-1Ra
T12428 1601-1614 JJ denotes Intracellular
T12427 1599-1600 . denotes .
T12426 1598-1599 NNP denotes ]
T12425 1596-1598 CD denotes 16
T12424 1595-1596 NNP denotes [
T12423 1593-1594 , denotes ,
T12422 1592-1593 NNP denotes ]
T12421 1590-1592 CD denotes 15
T12420 1589-1590 NNP denotes [
T12419 1587-1588 , denotes ,
T12418 1586-1587 NNP denotes ]
T12417 1584-1586 CD denotes 14
T12416 1583-1584 NNP denotes [
T12415 1576-1582 NN denotes cancer
T12414 1571-1575 NN denotes skin
T12413 1567-1570 CC denotes and
T12412 1565-1566 , denotes ,
T12411 1559-1565 NN denotes breast
T12410 1557-1558 , denotes ,
T12409 1549-1557 NN denotes prostate
T12408 1546-1548 IN denotes in
T12407 1534-1545 NN denotes progression
T12406 1528-1533 NN denotes tumor
T12405 1520-1527 VB denotes inhibit
T12404 1517-1519 TO denotes to
T12403 1511-1516 VBN denotes shown
T12402 1506-1510 VBN denotes been
T12401 1502-1505 VBZ denotes has
T12400 1495-1501 NN denotes IL-1Ra
T12399 1493-1494 . denotes .
T12398 1487-1493 NNS denotes tumors
T12397 1484-1486 IN denotes in
T12396 1477-1483 NN denotes IL-1Ra
T12395 1474-1476 IN denotes by
T12394 1461-1473 VBN denotes dysregulated
T12393 1458-1460 VB denotes be
T12392 1454-1457 MD denotes may
T12391 1447-1453 NN denotes system
T12390 1432-1446 JJ denotes IL-1-signaling
T12389 1428-1431 DT denotes the
T12388 1423-1427 IN denotes that
T12387 1414-1422 VBZ denotes suggests
T12386 1412-1413 , denotes ,
T12385 1406-1412 NNS denotes tumors
T12384 1403-1405 IN denotes in
T12383 1398-1402 NN denotes IL-1
T12382 1395-1397 IN denotes of
T12381 1388-1394 NN denotes change
T12380 1384-1387 DT denotes any
T12379 1376-1383 IN denotes without
T12378 1374-1375 , denotes ,
T12377 1368-1374 NN denotes IL-1Ra
T12376 1365-1367 IN denotes of
T12375 1354-1364 NN denotes expression
T12374 1345-1353 JJ denotes elevated
T12373 1341-1344 DT denotes The
T12372 1339-1340 . denotes .
T12371 1325-1339 NN denotes refractoriness
T12370 1322-1324 IN denotes of
T12369 1316-1321 NN denotes state
T12368 1306-1315 JJ denotes temporary
T12367 1304-1305 DT denotes a
T12366 1295-1303 VBG denotes creating
T12365 1291-1294 CC denotes and
T12364 1281-1290 VBG denotes signaling
T12363 1276-1280 JJ denotes IL-1
T12362 1272-1275 RP denotes off
T12361 1264-1271 VBG denotes turning
T12360 1260-1263 IN denotes for
T12359 1250-1259 NN denotes mechanism
T12358 1248-1249 DT denotes a
T12357 1237-1247 VBZ denotes represents
T12356 1226-1236 NN denotes antagonist
T12355 1217-1225 NN denotes receptor
T12354 1213-1216 DT denotes the
T12353 1210-1212 IN denotes of
T12352 1196-1209 NN denotes Up-regulation
T12351 1194-1195 . denotes .
T12350 1188-1194 NN denotes tissue
T12349 1179-1187 JJ denotes diseased
T12348 1175-1178 CC denotes and
T12347 1168-1174 JJ denotes normal
T12346 1165-1167 IN denotes in
T12345 1155-1164 VBG denotes signaling
T12344 1150-1154 JJ denotes IL-1
T12343 1147-1149 IN denotes of
T12342 1133-1146 NN denotes dysregulation
T12341 1129-1132 CC denotes and
T12340 1118-1128 NN denotes regulation
T12339 1114-1117 DT denotes the
T12338 1100-1113 VBG denotes understanding
T12337 1097-1099 IN denotes in
T12336 1088-1096 NN denotes interest
T12335 1085-1087 IN denotes of
T12334 1082-1084 VBZ denotes is
T12333 1071-1081 NN denotes antagonist
T12332 1067-1070 JJ denotes own
T12331 1063-1066 PRP$ denotes its
T12330 1056-1062 VB denotes induce
T12329 1053-1055 TO denotes to
T12328 1048-1052 NN denotes IL-1
T12327 1045-1047 IN denotes of
T12326 1037-1044 NN denotes ability
T12325 1033-1036 DT denotes The
T12324 1031-1032 . denotes .
T12323 1030-1031 NNP denotes ]
T12322 1028-1030 CD denotes 47
T12321 1027-1028 NNP denotes [
T12310 946-954 VB denotes regulate
T12309 943-945 TO denotes to
T12308 940-942 VBZ denotes is
T12307 933-939 NN denotes IL-1Ra
T12306 930-932 IN denotes of
T12305 921-929 NN denotes function
T12304 915-920 JJ denotes major
T12303 911-914 DT denotes the
T12302 906-910 IN denotes that
T12301 897-905 VBP denotes indicate
T12300 891-896 NNS denotes years
T12299 888-890 CD denotes 10
T12298 883-887 JJ denotes past
T12297 879-882 DT denotes the
T12296 874-878 IN denotes over
T12295 866-873 NNS denotes studies
T12294 858-865 JJ denotes various
T12293 855-857 IN denotes of
T12292 847-854 NNS denotes results
T12291 843-846 DT denotes The
T12290 841-842 . denotes .
T12289 832-841 NN denotes promotion
T12288 826-831 NN denotes tumor
T12287 823-825 TO denotes to
T12286 815-822 VBG denotes leading
T12285 809-814 NN denotes death
T12284 804-808 NN denotes cell
T12283 794-803 JJ denotes apoptotic
T12282 791-793 IN denotes of
T12281 779-790 NN denotes suppression
T12280 775-778 DT denotes the
T12279 771-774 CC denotes and
T12278 769-770 , denotes ,
T12277 758-769 NN denotes progression
T12276 752-757 NN denotes cycle
T12275 747-751 NN denotes cell
T12274 737-746 VBZ denotes increases
T12273 733-736 CC denotes and
T12272 731-732 , denotes ,
T12271 724-731 NNS denotes cancers
T12270 716-723 JJ denotes several
T12269 713-715 IN denotes in
T12268 707-712 NN denotes NF-κB
T12267 704-706 IN denotes of
T12266 693-703 NN denotes activation
T12265 689-692 DT denotes the
T12264 681-688 VBZ denotes induces
T12263 676-680 JJ denotes IL-1
T12262 671-675 IN denotes that
T12261 662-670 VBN denotes reported
T12260 657-661 VBN denotes been
T12259 653-656 VBZ denotes has
T12258 650-652 PRP denotes It
T12257 648-649 . denotes .
T12256 647-648 NNP denotes ]
T12255 645-647 CD denotes 46
T12254 644-645 NNP denotes [
T12253 639-643 NNP denotes IL-1
T12252 636-638 IN denotes of
T12251 628-635 NNS denotes effects
T12250 612-627 JJ denotes proinflammatory
T12249 608-611 DT denotes the
T12248 599-607 VB denotes abrogate
T12247 596-598 TO denotes to
T12246 589-595 NN denotes IL-1Ra
T12245 586-588 IN denotes of
T12244 578-585 NN denotes ability
T12243 574-577 DT denotes the
T12242 561-573 VBN denotes demonstrated
T12241 556-560 VBP denotes have
T12240 548-555 NNS denotes studies
T12239 540-547 JJ denotes several
T12238 538-539 , denotes ,
T12237 529-538 RB denotes Similarly
T12236 527-528 . denotes .
T12235 526-527 NNP denotes ]
T12234 524-526 CD denotes 43
T12233 523-524 NNP denotes [
T12232 518-522 NNS denotes mice
T12231 502-517 JJ denotes Colon26-bearing
T12230 499-501 IN denotes in
T12229 489-498 NN denotes apoptosis
T12228 485-488 CC denotes and
T12227 475-484 JJ denotes caspase-3
T12226 472-474 IN denotes of
T12225 461-471 NN denotes activation
T12224 457-460 DT denotes the
T12223 449-456 IN denotes through
T12222 441-448 NNS denotes effects
T12221 430-440 JJ denotes anti-tumor
T12220 426-429 DT denotes the
T12219 423-425 TO denotes to
T12218 411-422 VBZ denotes contributes
T12217 405-410 NNP denotes IL-10
T12216 401-404 DT denotes the
T12215 398-400 IN denotes by
T12214 392-397 NNP denotes NF-κB
T12213 389-391 IN denotes of
T12212 378-388 NNP denotes Inhibition
T12211 376-377 . denotes .
T12210 375-376 NNP denotes ]
T12209 373-375 CD denotes 45
T12208 372-373 NNP denotes [
T12207 367-371 NN denotes vivo
T12206 364-366 IN denotes in
T12205 360-363 CC denotes and
T12204 358-359 NNP denotes ]
T12203 356-358 CD denotes 44
T12202 355-356 NNP denotes [
T12201 349-354 NN denotes vitro
T12200 346-348 IN denotes in
T12199 341-345 DT denotes both
T12198 335-340 NNP denotes NF-κB
T12197 325-334 VBD denotes activated
T12196 310-324 RB denotes constitutively
T12195 301-309 NNS denotes inhibits
T12194 295-300 JJ denotes IL-10
T12193 293-294 . denotes .
T12192 292-293 NNP denotes ]
T12191 290-292 CD denotes 43
T12190 289-290 NNP denotes [
T12189 287-288 , denotes ,
T12188 286-287 NNP denotes ]
T12187 284-286 CD denotes 42
T12186 283-284 NNP denotes [
T12185 276-282 NN denotes factor
T12184 258-275 JJ denotes anti-inflammatory
T12183 255-257 DT denotes an
T12182 252-254 IN denotes as
T12181 247-251 RB denotes well
T12180 244-246 RB denotes as
T12179 237-243 NN denotes factor
T12178 226-236 JJ denotes anti-tumor
T12177 223-225 DT denotes an
T12176 220-222 IN denotes as
T12175 214-219 VBN denotes known
T12174 209-213 RB denotes well
T12173 206-208 VBZ denotes is
T12172 204-205 -RRB- denotes )
T12171 199-204 NN denotes IL-10
T12170 198-199 -LRB- denotes (
T12169 195-197 CD denotes 10
T12168 183-194 NN denotes interleukin
T12167 179-182 DT denotes The
T12166 177-178 . denotes .
T12165 176-177 NNP denotes ]
T12164 174-176 CD denotes 41
T12163 173-174 NNP denotes [
T12162 167-172 NNS denotes cells
T12161 161-166 NN denotes tumor
T12160 158-160 IN denotes in
T12159 149-157 NNS denotes pathways
T12158 143-148 JJ denotes NF-κB
T12157 134-142 VBP denotes activate
T12156 132-133 , denotes ,
T12155 128-132 NNP denotes IL-8
T12154 124-127 CC denotes and
T12153 119-123 NNP denotes IL-6
T12152 117-118 , denotes ,
T12151 113-117 NNP denotes IL-1
T12150 103-112 VBG denotes including
T12149 101-102 , denotes ,
T12148 92-101 NNS denotes cytokines
T12147 79-91 JJ denotes Inflammatory
T12146 77-78 . denotes .
T12145 72-77 NNP denotes NF-κB
T12144 61-71 VBG denotes regulating
T12143 58-60 IN denotes by
T12142 51-57 NN denotes growth
T12141 45-50 NN denotes tumor
T12140 38-44 VB denotes affect
T12139 29-37 JJ denotes cytokine
T12138 24-28 IN denotes that
T12137 17-23 VBD denotes showed
T12136 9-16 NNS denotes studies
T12135 0-8 JJ denotes Numerous
T12320 1017-1026 NNS denotes functions
T12319 1013-1016 PRP$ denotes its
T12318 1004-1012 VBG denotes blocking
T12317 990-1003 RB denotes competitively
T12316 987-989 IN denotes by
T12315 982-986 NN denotes IL-1
T12314 979-981 IN denotes of
T12313 971-978 NNS denotes effects
T12312 959-970 JJ denotes pleiotropic
T12311 955-958 DT denotes the
R7990 T12135 T12136 amod Numerous,studies
R7992 T12136 T12137 nsubj studies,showed
R7993 T12137 T12137 ROOT showed,showed
R7995 T12138 T12140 mark that,affect
R7996 T12139 T12140 nsubj cytokine,affect
R7997 T12140 T12137 ccomp affect,showed
R7999 T12141 T12142 compound tumor,growth
R8000 T12142 T12140 dobj growth,affect
R8001 T12143 T12140 prep by,affect
R8003 T12144 T12143 pcomp regulating,by
R8004 T12145 T12144 dobj NF-κB,regulating
R8006 T12146 T12137 punct .,showed
R8007 T12147 T12148 amod Inflammatory,cytokines
R8008 T12148 T12157 nsubj cytokines,activate
R8010 T12149 T12148 punct ",",cytokines
R8011 T12150 T12148 prep including,cytokines
R8013 T12151 T12150 pobj IL-1,including
R8014 T12152 T12151 punct ",",IL-1
R8015 T12153 T12151 conj IL-6,IL-1
R8017 T12154 T12153 cc and,IL-6
R8018 T12155 T12153 conj IL-8,IL-6
R8019 T12156 T12148 punct ",",cytokines
R8021 T12157 T12157 ROOT activate,activate
R8022 T12158 T12159 amod NF-κB,pathways
R8023 T12159 T12157 dobj pathways,activate
R8025 T12160 T12159 prep in,pathways
R8026 T12161 T12162 compound tumor,cells
R8027 T12162 T12160 pobj cells,in
R8029 T12163 T12165 nmod [,]
R8030 T12164 T12165 nummod 41,]
R8032 T12165 T12159 conj ],pathways
R8033 T12166 T12157 punct .,activate
R8034 T12167 T12175 det The,known
R8036 T12168 T12175 nsubjpass interleukin,known
R8037 T12169 T12168 nummod 10,interleukin
R8038 T12170 T12168 punct (,interleukin
R8040 T12171 T12168 appos IL-10,interleukin
R8042 T12172 T12168 punct ),interleukin
R8043 T12173 T12175 auxpass is,known
R8044 T12174 T12175 advmod well,known
R8046 T12175 T12175 ROOT known,known
R8047 T12176 T12175 prep as,known
R8048 T12177 T12179 det an,factor
R8050 T12178 T12179 amod anti-tumor,factor
R8051 T12179 T12176 pobj factor,as
R8053 T12180 T12182 advmod as,as
R8054 T12181 T12182 advmod well,as
R8055 T12182 T12179 cc as,factor
R8057 T12183 T12185 det an,factor
R8058 T12184 T12185 amod anti-inflammatory,factor
R8060 T12185 T12179 conj factor,factor
R8061 T12186 T12188 nmod [,]
R8062 T12187 T12188 nummod 42,]
R8064 T12188 T12185 appos ],factor
R8065 T12189 T12188 punct ",",]
R8066 T12190 T12192 nmod [,]
R8068 T12191 T12192 nummod 43,]
R8069 T12192 T12188 appos ],]
R8070 T12193 T12175 punct .,known
R8072 T12194 T12195 amod IL-10,inhibits
R8073 T12195 T12197 nsubj inhibits,activated
R8074 T12196 T12197 advmod constitutively,activated
R8076 T12197 T12197 ROOT activated,activated
R8077 T12198 T12199 compound NF-κB,both
R8078 T12199 T12200 preconj both,in
R8080 T12200 T12197 prep in,activated
R8081 T12201 T12204 amod vitro,]
R8082 T12202 T12204 nmod [,]
R8084 T12203 T12204 nummod 44,]
R8085 T12204 T12200 pobj ],in
R8087 T12205 T12200 cc and,in
R8088 T12206 T12200 conj in,in
R8089 T12207 T12208 compound vivo,[
R8090 T12208 T12206 pobj [,in
R8091 T12209 T12210 nummod 45,]
R8092 T12210 T12208 appos ],[
R8094 T12211 T12197 punct .,activated
R8097 T12212 T12218 nsubj Inhibition,contributes
R8099 T12213 T12212 prep of,Inhibition
R8101 T12214 T12213 pobj NF-κB,of
R8102 T12215 T12212 prep by,Inhibition
R8103 T12216 T12217 det the,IL-10
R8104 T12217 T12215 pobj IL-10,by
R8105 T12218 T12218 ROOT contributes,contributes
R8107 T12219 T12218 prep to,contributes
R8108 T12220 T12222 det the,effects
R8109 T12221 T12222 amod anti-tumor,effects
R8111 T12222 T12219 pobj effects,to
R8112 T12223 T12222 prep through,effects
R8113 T12224 T12225 det the,activation
R8115 T12225 T12223 pobj activation,through
R8116 T12226 T12225 prep of,activation
R8117 T12227 T12226 pobj caspase-3,of
R8118 T12309 T12310 aux to,regulate
R8119 T12228 T12227 cc and,caspase-3
R8120 T12229 T12227 conj apoptosis,caspase-3
R8121 T12230 T12225 prep in,activation
R8122 T12231 T12232 amod Colon26-bearing,mice
R8123 T12232 T12230 pobj mice,in
R8124 T12310 T12308 xcomp regulate,is
R8125 T12233 T12235 nmod [,]
R8126 T12234 T12235 nummod 43,]
R8127 T12235 T12225 appos ],activation
R8128 T12311 T12313 det the,effects
R8129 T12236 T12218 punct .,contributes
R8130 T12237 T12242 advmod Similarly,demonstrated
R8131 T12238 T12242 punct ",",demonstrated
R8132 T12312 T12313 amod pleiotropic,effects
R8133 T12239 T12240 amod several,studies
R8134 T12240 T12242 nsubj studies,demonstrated
R8135 T12241 T12242 aux have,demonstrated
R8136 T12313 T12310 dobj effects,regulate
R8137 T12242 T12242 ROOT demonstrated,demonstrated
R8138 T12243 T12244 det the,ability
R8139 T12244 T12242 dobj ability,demonstrated
R8140 T12245 T12244 prep of,ability
R8141 T12246 T12245 pobj IL-1Ra,of
R8142 T12247 T12248 aux to,abrogate
R8143 T12314 T12313 prep of,effects
R8144 T12248 T12244 acl abrogate,ability
R8145 T12249 T12251 det the,effects
R8146 T12315 T12314 pobj IL-1,of
R8147 T12316 T12310 prep by,regulate
R8148 T12250 T12251 amod proinflammatory,effects
R8149 T12317 T12318 advmod competitively,blocking
R8150 T12251 T12248 dobj effects,abrogate
R8151 T12252 T12251 prep of,effects
R8152 T12318 T12316 pcomp blocking,by
R8153 T12253 T12254 compound IL-1,[
R8154 T12254 T12252 pobj [,of
R8155 T12255 T12256 nummod 46,]
R8156 T12319 T12320 poss its,functions
R8157 T12256 T12251 conj ],effects
R8158 T12257 T12242 punct .,demonstrated
R8159 T12258 T12261 nsubjpass It,reported
R8160 T12320 T12318 dobj functions,blocking
R8161 T12259 T12261 aux has,reported
R8162 T12260 T12261 auxpass been,reported
R8163 T12321 T12323 nmod [,]
R8164 T12261 T12261 ROOT reported,reported
R8165 T12262 T12264 mark that,induces
R8166 T12263 T12264 nsubj IL-1,induces
R8167 T12322 T12323 nummod 47,]
R8168 T12264 T12261 ccomp induces,reported
R8169 T12265 T12266 det the,activation
R8170 T12266 T12264 dobj activation,induces
R8171 T12323 T12318 dobj ],blocking
R8172 T12267 T12266 prep of,activation
R8173 T12268 T12267 pobj NF-κB,of
R8174 T12269 T12266 prep in,activation
R8175 T12324 T12301 punct .,indicate
R8176 T12270 T12271 amod several,cancers
R8177 T12271 T12269 pobj cancers,in
R8178 T12272 T12261 punct ",",reported
R8179 T12325 T12326 det The,ability
R8180 T12273 T12261 cc and,reported
R8181 T12274 T12261 conj increases,reported
R8182 T12275 T12276 compound cell,cycle
R8183 T12326 T12334 nsubj ability,is
R8184 T12276 T12277 compound cycle,progression
R8185 T12277 T12274 dobj progression,increases
R8186 T12278 T12274 punct ",",increases
R8187 T12327 T12326 prep of,ability
R8188 T12279 T12274 cc and,increases
R8189 T12280 T12281 det the,suppression
R8190 T12281 T12274 conj suppression,increases
R8191 T12282 T12281 prep of,suppression
R8192 T12283 T12285 amod apoptotic,death
R8193 T12284 T12285 compound cell,death
R8194 T12328 T12327 pobj IL-1,of
R8195 T12285 T12282 pobj death,of
R8196 T12286 T12281 acl leading,suppression
R8197 T12287 T12286 prep to,leading
R8198 T12329 T12330 aux to,induce
R8199 T12288 T12289 compound tumor,promotion
R8200 T12289 T12287 pobj promotion,to
R8201 T12290 T12261 punct .,reported
R8202 T12330 T12326 acl induce,ability
R8203 T12291 T12292 det The,results
R8204 T12292 T12301 nsubj results,indicate
R8205 T12331 T12333 poss its,antagonist
R8206 T12293 T12292 prep of,results
R8207 T12294 T12295 amod various,studies
R8208 T12295 T12293 pobj studies,of
R8209 T12332 T12333 amod own,antagonist
R8210 T12296 T12292 prep over,results
R8211 T12297 T12300 det the,years
R8212 T12298 T12300 amod past,years
R8213 T12333 T12330 dobj antagonist,induce
R8214 T12299 T12300 nummod 10,years
R8215 T12300 T12296 pobj years,over
R8216 T12334 T12334 ROOT is,is
R8217 T12301 T12301 ROOT indicate,indicate
R8218 T12302 T12308 mark that,is
R8219 T12303 T12305 det the,function
R8220 T12335 T12334 prep of,is
R8221 T12304 T12305 amod major,function
R8222 T12305 T12308 nsubj function,is
R8223 T12336 T12335 pobj interest,of
R8224 T12306 T12305 prep of,function
R8225 T12307 T12306 pobj IL-1Ra,of
R8226 T12308 T12301 ccomp is,indicate
R8227 T12337 T12336 prep in,interest
R8228 T12338 T12337 pcomp understanding,in
R8229 T12339 T12340 det the,regulation
R8230 T12406 T12407 compound tumor,progression
R8231 T12407 T12405 dobj progression,inhibit
R8232 T12340 T12338 dobj regulation,understanding
R8233 T12408 T12407 prep in,progression
R8234 T12341 T12340 cc and,regulation
R8235 T12409 T12408 pobj prostate,in
R8236 T12410 T12409 punct ",",prostate
R8237 T12342 T12340 conj dysregulation,regulation
R8238 T12411 T12409 conj breast,prostate
R8239 T12412 T12411 punct ",",breast
R8240 T12413 T12411 cc and,breast
R8241 T12414 T12415 compound skin,cancer
R8242 T12415 T12411 conj cancer,breast
R8243 T12416 T12418 nmod [,]
R8244 T12343 T12340 prep of,regulation
R8245 T12417 T12418 nummod 14,]
R8246 T12418 T12407 appos ],progression
R8247 T12344 T12345 amod IL-1,signaling
R8248 T12419 T12418 punct ",",]
R8249 T12420 T12422 nmod [,]
R8250 T12421 T12422 nummod 15,]
R8251 T12345 T12343 pobj signaling,of
R8252 T12422 T12418 conj ],]
R8253 T12423 T12422 punct ",",]
R8254 T12346 T12340 prep in,regulation
R8255 T12424 T12422 conj [,]
R8256 T12425 T12426 nummod 16,]
R8257 T12426 T12422 conj ],]
R8258 T12427 T12403 punct .,shown
R8259 T12347 T12350 amod normal,tissue
R8260 T12428 T12429 amod Intracellular,IL-1Ra
R8261 T12429 T12433 nsubj IL-1Ra,inhibits
R8262 T12430 T12431 punct (,icIL-1Ra
R8263 T12348 T12347 cc and,normal
R8264 T12431 T12429 appos icIL-1Ra,IL-1Ra
R8265 T12432 T12431 punct ),icIL-1Ra
R8266 T12433 T12433 ROOT inhibits,inhibits
R8267 T12434 T12433 dobj IL-6,inhibits
R8268 T12349 T12347 conj diseased,normal
R8269 T12435 T12434 cc and,IL-6
R8270 T12436 T12437 amod IL-8,production
R8271 T12437 T12434 conj production,IL-6
R8272 T12350 T12346 pobj tissue,in
R8273 T12438 T12437 prep in,production
R8274 T12439 T12440 amod Caco-2,cells
R8275 T12440 T12438 pobj cells,in
R8276 T12351 T12334 punct .,is
R8277 T12441 T12433 prep by,inhibits
R8278 T12442 T12441 pcomp blocking,by
R8279 T12443 T12444 amod NF-κB,pathways
R8280 T12352 T12357 nsubj Up-regulation,represents
R8281 T12444 T12442 dobj pathways,blocking
R8282 T12445 T12447 nmod [,]
R8283 T12446 T12447 nummod 37,]
R8284 T12353 T12352 prep of,Up-regulation
R8285 T12447 T12442 dobj ],blocking
R8286 T12448 T12433 punct .,inhibits
R8287 T12449 T12450 nsubj We,found
R8288 T12354 T12356 det the,antagonist
R8289 T12450 T12450 ROOT found,found
R8290 T12451 T12458 mark that,elevated
R8291 T12452 T12453 det the,levels
R8292 T12453 T12458 nsubjpass levels,elevated
R8293 T12454 T12453 prep of,levels
R8294 T12455 T12454 pobj IL-1Ra,of
R8295 T12355 T12356 compound receptor,antagonist
R8296 T12456 T12458 auxpass were,elevated
R8297 T12457 T12458 advmod significantly,elevated
R8298 T12458 T12450 ccomp elevated,found
R8299 T12459 T12458 prep in,elevated
R8300 T12356 T12353 pobj antagonist,of
R8301 T12460 T12462 det the,tissues
R8302 T12461 T12462 compound tumor,tissues
R8303 T12462 T12459 pobj tissues,in
R8304 T12357 T12357 ROOT represents,represents
R8305 T12463 T12462 prep of,tissues
R8306 T12464 T12468 nummod CCR5,mice
R8307 T12465 T12468 nummod −,mice
R8308 T12358 T12359 det a,mechanism
R8309 T12466 T12468 compound /,mice
R8310 T12467 T12468 compound −,mice
R8311 T12468 T12463 pobj mice,of
R8312 T12359 T12357 dobj mechanism,represents
R8313 T12469 T12468 acl inoculated,mice
R8314 T12470 T12469 prep with,inoculated
R8315 T12471 T12473 compound B16,cells
R8316 T12360 T12359 prep for,mechanism
R8317 T12472 T12473 compound melanoma,cells
R8318 T12473 T12470 pobj cells,with
R8319 T12474 T12450 punct .,found
R8320 T12361 T12360 pcomp turning,for
R8321 T12475 T12480 advcl Taken,indicate
R8322 T12476 T12475 advmod together,Taken
R8323 T12477 T12480 punct ",",indicate
R8324 T12362 T12361 prt off,turning
R8325 T12478 T12479 det these,data
R8326 T12479 T12480 nsubj data,indicate
R8327 T12363 T12361 dobj IL-1,turning
R8328 T12480 T12480 ROOT indicate,indicate
R8329 T12481 T12485 nsubjpass IL-1Ra,involved
R8330 T12482 T12485 aux could,involved
R8331 T12364 T12361 conj signaling,turning
R8332 T12483 T12485 auxpass be,involved
R8333 T12365 T12364 cc and,signaling
R8334 T12484 T12485 advmod critically,involved
R8335 T12366 T12364 conj creating,signaling
R8336 T12485 T12480 ccomp involved,indicate
R8337 T12486 T12485 prep in,involved
R8338 T12367 T12369 det a,state
R8339 T12368 T12369 amod temporary,state
R8340 T12487 T12490 det the,inhibition
R8341 T12488 T12489 compound tumor,growth
R8342 T12489 T12490 compound growth,inhibition
R8343 T12369 T12366 dobj state,creating
R8344 T12490 T12486 pobj inhibition,in
R8345 T12491 T12490 prep of,inhibition
R8346 T12492 T12496 nummod CCR5,mice
R8347 T12370 T12369 prep of,state
R8348 T12493 T12496 nummod −,mice
R8349 T12494 T12496 nmod /,mice
R8350 T12371 T12370 pobj refractoriness,of
R8351 T12495 T12496 compound −,mice
R8352 T12496 T12491 pobj mice,of
R8353 T12497 T12485 prep through,involved
R8354 T12372 T12357 punct .,represents
R8355 T12498 T12499 det the,inactivation
R8356 T12499 T12497 pobj inactivation,through
R8357 T12500 T12499 prep of,inactivation
R8358 T12501 T12500 pobj NF-κB,of
R8359 T12373 T12375 det The,expression
R8360 T12502 T12499 prep in,inactivation
R8361 T12374 T12375 amod elevated,expression
R8362 T12375 T12387 nsubj expression,suggests
R8363 T12376 T12375 prep of,expression
R8364 T12377 T12376 pobj IL-1Ra,of
R8365 T12378 T12375 punct ",",expression
R8366 T12503 T12505 det the,study
R8367 T12504 T12505 amod present,study
R8368 T12505 T12502 pobj study,in
R8369 T12379 T12375 prep without,expression
R8370 T12506 T12480 punct .,indicate
R8372 T12380 T12381 det any,change
R8376 T12381 T12379 pobj change,without
R8380 T12382 T12381 prep of,change
R8383 T12383 T12382 pobj IL-1,of
R8387 T12384 T12381 prep in,change
R8394 T12385 T12384 pobj tumors,in
R8398 T12386 T12387 punct ",",suggests
R8402 T12387 T12387 ROOT suggests,suggests
R8406 T12388 T12394 mark that,dysregulated
R8411 T12389 T12391 det the,system
R8414 T12390 T12391 amod IL-1-signaling,system
R8418 T12391 T12394 nsubjpass system,dysregulated
R8422 T12392 T12394 aux may,dysregulated
R8425 T12393 T12394 auxpass be,dysregulated
R8429 T12394 T12387 ccomp dysregulated,suggests
R8433 T12395 T12394 agent by,dysregulated
R8437 T12396 T12395 pobj IL-1Ra,by
R8444 T12397 T12394 prep in,dysregulated
R8448 T12398 T12397 pobj tumors,in
R8449 T12399 T12387 punct .,suggests
R8451 T12400 T12403 nsubjpass IL-1Ra,shown
R8455 T12401 T12403 aux has,shown
R8458 T12402 T12403 auxpass been,shown
R8462 T12403 T12403 ROOT shown,shown
R8465 T12404 T12405 aux to,inhibit
R8469 T12405 T12403 xcomp inhibit,shown

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T11305 1983-1995 Negative_regulation denotes inactivation
T11304 1999-2004 Protein denotes NF-κB
T11303 1958-1962 Protein denotes CCR5
T11302 1888-1894 Protein denotes IL-1Ra
T11301 1770-1778 Positive_regulation denotes elevated
T11300 1744-1750 Protein denotes IL-1Ra
T11299 1686-1694 Negative_regulation denotes blocking
T11298 1656-1666 Gene_expression denotes production
T11297 1656-1666 Gene_expression denotes production
T11296 1695-1700 Protein denotes NF-κB
T11295 1651-1655 Protein denotes IL-8
T11294 1642-1646 Protein denotes IL-6
T11293 1623-1631 Protein denotes icIL-1Ra
T11292 1615-1621 Protein denotes IL-1Ra
T11291 1495-1501 Protein denotes IL-1Ra
T11290 1345-1353 Positive_regulation denotes elevated
T11289 1354-1364 Gene_expression denotes expression
T11288 1477-1483 Protein denotes IL-1Ra
T11287 1398-1402 Protein denotes IL-1
T11286 1368-1374 Protein denotes IL-1Ra
T11285 1276-1280 Protein denotes IL-1
T11284 1150-1154 Protein denotes IL-1
T11283 1048-1052 Protein denotes IL-1
T11282 982-986 Protein denotes IL-1
T11281 933-939 Protein denotes IL-1Ra
T11280 693-703 Positive_regulation denotes activation
T11279 707-712 Protein denotes NF-κB
T11278 676-680 Protein denotes IL-1
T11277 589-595 Protein denotes IL-1Ra
T11276 461-471 Positive_regulation denotes activation
T11275 378-388 Negative_regulation denotes Inhibition
T11274 378-388 Negative_regulation denotes Inhibition
T11273 475-484 Protein denotes caspase-3
T11272 405-410 Protein denotes IL-10
T11271 392-397 Protein denotes NF-κB
T11270 325-334 Positive_regulation denotes activated
T11269 335-340 Protein denotes NF-κB
T11268 295-300 Protein denotes IL-10
T11267 199-204 Protein denotes IL-10
T11266 183-197 Protein denotes interleukin 10
T11265 134-142 Positive_regulation denotes activate
T11264 134-142 Positive_regulation denotes activate
T11263 134-142 Positive_regulation denotes activate
T11262 143-148 Protein denotes NF-κB
T11261 128-132 Protein denotes IL-8
T11260 119-123 Protein denotes IL-6
T11259 113-117 Protein denotes IL-1
T11258 61-71 Regulation denotes regulating
T11257 72-77 Protein denotes NF-κB
R7459 T11257 T11258 themeOf NF-κB,regulating
R7461 T11259 T11263 causeOf IL-1,activate
R7462 T11260 T11264 causeOf IL-6,activate
R7463 T11261 T11265 causeOf IL-8,activate
R7464 T11262 T11263 themeOf NF-κB,activate
R7465 T11262 T11264 themeOf NF-κB,activate
R7466 T11262 T11265 themeOf NF-κB,activate
R7468 T11269 T11270 themeOf NF-κB,activated
R7469 T11271 T11274 themeOf NF-κB,Inhibition
R7470 T11272 T11275 themeOf IL-10,Inhibition
R7471 T11273 T11276 themeOf caspase-3,activation
R7474 T11278 T11280 causeOf IL-1,activation
R7475 T11279 T11280 themeOf NF-κB,activation
R7478 T11286 T11289 themeOf IL-1Ra,expression
R7479 T11289 T11290 themeOf expression,elevated
R7482 T11294 T11297 themeOf IL-6,production
R7483 T11295 T11298 themeOf IL-8,production
R7484 T11296 T11299 themeOf NF-κB,blocking
R7486 T11300 T11301 themeOf IL-1Ra,elevated
R7488 T11304 T11305 themeOf NF-κB,inactivation